文献速递炎症性肠病

炎症性肠病住院患者艰难梭菌感染的近期趋势及相关危险因素

Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
PubMed 文献 · Aliment Pharmacol Ther · 2023-10-24

该研究基于2010至2020年全国再入院数据库的回顾性分析,纳入至少住院一次的2521935例炎症性肠病(IBD)患者,评估艰难梭菌感染(CDI)率变化及相关因素。结果显示CDI率在2010至2015年上升(克罗恩病:1.64%至3.32%,p<0.001;溃疡性结肠炎:4.15%至5.81%,p<0.001),2016至2020年稳步下降(克罗恩病:3.15%至2.27%,p<0.001;溃疡性结肠炎:5.04%至4.27%,p<0.001)。CDI与查尔森-德约合并症指数、公共保险、医院规模及城市教学医院相关,并与住院死亡率升高相关。

要点

  • IBD住院患者CDI率2010至2015年上升,2016至2020年下降。
  • CDI与合并症指数、公共保险、医院规模及城市教学医院相关。
  • CDI与IBD住院患者死亡率升高相关。

核心结论

  • IBD住院患者中CDI率最初上升,但自2015年以来已下降。
  • 合并症增加、医院规模大、公共保险和城市教学医院与更高的CDI率相关。
  • CDI与IBD住院患者死亡率升高相关。
  • 持续警惕、感染控制和CDI治疗有助于继续感染率下降的趋势。

研究设计与样本

  • 回顾性分析,使用2010至2020年全国再入院数据库。
  • 研究对象为至少住院一次的克罗恩病或溃疡性结肠炎患者,共2521935例。
  • 使用国际疾病分类代码评估CDI率的纵向变化。
  • 采用多变量逻辑回归评估患者和医院相关因素与CDI的关联。

主要发现

  • CDI率在IBD相关住院中从2010至2015年上升:克罗恩病从1.64%至3.32%(p<0.001);溃疡性结肠炎从4.15%至5.81%(p<0.001)。
  • 2016至2020年CDI率稳步下降:克罗恩病从3.15%至2.27%(p<0.001);溃疡性结肠炎从5.04%至4.27%(p<0.001)。
  • 在多变量模型中,CDI与查尔森-德约合并症指数、公共保险和医院规模相关。
  • CDI与死亡率升高相关。

关键数值与推荐

  • CDI率上升期(2010至2015年):克罗恩病1.64%至3.32%(p<0.001);溃疡性结肠炎4.15%至5.81%(p<0.001)。
  • CDI率下降期(2016至2020年):克罗恩病3.15%至2.27%(p<0.001);溃疡性结肠炎5.04%至4.27%(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clostridioides difficile infections (CDIs) are common among patients with inflammatory bowel disease (IBD) and can mimic and exacerbate IBD flares, thus warranting appropriate testing during flares. AIMS: To examine recent trends in rates of CDI and associated risk factors in hospitalized IBD patients, which may better inform targeted interventions to mitigate the risk of infection. METHODS: This is a retrospective analysis using the Nationwide Readmissions Database from 2010 to 2020 of hospitalized individuals with Crohn's disease (CD) or ulcerative colitis (UC). Longitudinal changes in rates of CDI were evaluated using International Classification of Diseases codes. Multivariable logistic regression evaluated the association between patient- and hospital-related factors and CDI. RESULTS: There were 2,521,935 individuals with IBD who were hospitalized at least once during the study period. Rates of CDI in IBD-related hospitalizations increased from 2010 to 2015 (CD: 1.64%-3.32%, p < 0.001; UC: 4.15%-5.81%, p < 0.001), followed by a steady decline from 2016 to 2020 (CD: 3.15%-2.27%, p < 0.001; UC: 5.04%-4.27%, p < 0.001). In multivariable models, CDI was associated with the Charlson-Deyo comorbidity index, public insurance, and hospital size. CDI was associated with increased mortality. CONCLUSIONS: Rates of CDI among hospitalized patients with IBD had initially increased, but have declined since 2015. Increased comorbidity, large hospital size, public insurance, and urban teaching hospitals were associated with higher rates of CDI. CDI was associated with increased mortality in hospitalized patients with IBD. Continued vigilance, infection control, and treatment of CDI can help continue the trend of declining infection rates.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Spartz EJ, DeDecker LC, Fansiwala KM, et al. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2023. PMID: 37873878. doi:10.1111/apt.17777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。